{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-298895","form_type":"8-K","ticker":"AGIO","cik":"0001439222","company_name":"AGIOS PHARMACEUTICALS, INC.","filed_at":"2022-12-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.667198+00:00","generated_at":"2026-06-21T08:47:15.411757+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Agios appoints Tsveta Milanova as CCO effective Jan 3, 2023; Richa Poddar departs Dec 31, 2022","bullets":["Tsveta Milanova named Chief Commercial Officer, will succeed Richa Poddar effective Jan 3, 2023.","Milanova previously SVP US Commercial at Alexion; brings rare disease commercial launch experience.","Poddar will receive $450K severance plus 2022 target bonus and 12-month COBRA coverage.","Milanova's base salary $510K, target bonus 45%, sign-on bonus $150K, plus equity grants."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-298895","json":"https://secwatch.observer/filing/0001193125-22-298895.json","markdown":"https://secwatch.observer/filing/0001193125-22-298895.md","text":"https://secwatch.observer/filing/0001193125-22-298895.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1439222/000119312522298895/0001193125-22-298895-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1439222/000119312522298895/d407010d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T08:47:15.411757+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"be1b22133f","claim":"Tsveta Milanova was appointed as Chief Commercial Officer at AGIOS PHARMACEUTICALS, INC..","evidence_excerpt":"the Company appointed Tsveta Milanova as the Company’s Chief Commercial Officer, effective as of January 3, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1439222/000119312522298895/0001193125-22-298895-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}